Gencor Unveils New Health Solutions at Vitafoods Europe 2025

At the recent Vitafoods Europe 2025 event, leading research findings from Gencor were highlighted by Cristopher Bailey, the company’s director of scientific affairs. His presentation focused on innovative ingredients that address a variety of health concerns for both men and women.

Key Discoveries in Men’s Health

One significant finding discussed was the research surrounding Tesnor, an ingredient that has shown potential in enhancing testosterone levels in men. This study points to promising sexual health benefits, which could offer new avenues for tackling men’s health issues.

Advancements in Women’s Health

On the women’s health front, Bailey presented compelling data regarding Levagen+. This ingredient has been shown to alleviate menstrual pain, providing women with an effective option for managing discomfort.

Metabolic Health Insights

Bailey also shed light on the metabolic health sector, introducing Gencor’s Trpti ingredient. This innovative solution has been identified as a stimulant for GLP-1 hormones, which play a crucial role in metabolic regulation and can aid in weight management and blood sugar control.

Market Trends and Future Demand

Maggie McNamara, Gencor’s global marketing director, forecasted a sustained demand for products focused on women’s health, healthy aging, and mood stability. These trends suggest a growing consumer interest in holistic health solutions that cater to these areas.

Conclusion

The findings presented at Vitafoods Europe 2025 not only highlight Gencor’s commitment to advancing health solutions but also underscore the importance of research-driven development in the wellness industry. As consumer demands evolve, innovations like Tesnor, Levagen+, and Trpti are set to play a pivotal role in addressing modern health challenges.